Bringing Clinical Trials to Life

Dermatology

Together, Cu-Tech and Synteract create the leading dermatology CRO, with global capabilities and unparalleled access to sites and patients. Our focus on novel and required dermatology drugs provides dedicated research services unmatched in the market.
More...

Neuro Degenerative

Neuro degenerative disorders are some of the most confounding and complex to affect people. Our specialized experience in these trials aids you in developing treatments that improve functioning and help the lives of both patients and caregivers…
More...

Oncology

Like our clients, we are committed to the quest to cure cancer. But cancer is not just a single disease. It takes deep trial knowledge to know how to address its many forms. Learn how Synteract has stayed ahead of the trends leading towards new treatments…
More...

Pediatrics

Pediatric trials run the gamut of indications in drug development, but they all have primary things in common – working with children and their families requires specialized expertise and deep knowledge of regulatory requirements….
More...

Rare & Orphan Diseases

Rare and orphan diseases have unique characteristics, not the least of which is finding the right population for your trials. We know the investigators and study sites that can help to address your recruitment goals, among other challenges…
More...

4/30/2019 - 5/1/2019 : Clinical Operations in Oncology Trials West Coast Booth # 13 More...

4/18/2019: On April 29 we will hold a Webinar about the role caregivers play in clinical trials, especially in trials that are focused on rare or neurological conditions. More...

4/16/2019: Pediatric Rare Disease – A Collaborative Approach: FDA Draft Guidance - The emergence of concomitant trials for multiple investigational drug products for the treatment of rare diseases in pediatrics can pose significant challenges to effective drug development due to the limited number of patients worldwide with any given rare condition.

Synteract Blog 

4/23/2019: Find out how our team rose to the occasion and managed safety services for a sponsor’s three compounds in 10 #oncology trials: http://ow.ly/xfpP50quFlg

Synteract on LinkedIn

4/22/2019: Find out how our deep knowledge of the #dermatology clinical drug development process can take your study to the ne… https://t.co/3ZzSEQD7rh

Synteract Twitter Feed
x

Submit RFI / RFP

..
By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required